Vomacur anti-nausea medication

Vomacur is a well-known German pharmaceutical brand specifically used for the treatment of nausea, vomiting, and motion sickness. The active ingredient is dimenhydrinate, which acts as an antihistamine with antiemetic properties. It is a staple in many German households and pharmacies for travel-related wellness.

The brand was originally developed and marketed by Hexal AG, a company founded in Tegernsee, Germany. Since then, it has become part of one of the world's largest pharmaceutical families. Hexal is now a key subsidiary within the Sandoz division. As of 2023 and moving forward, Sandoz has transitioned into an independent, publicly-traded company after successfully spinning off from the Novartis Group, maintaining its headquarters in Basel, Switzerland.